Cinemark Hldgs Inc (CNK) reported $3.1B in revenue for fiscal year 2025, up 2.1% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
CNK’s dominant mechanic is profit volatility on a stable revenue base, with financing structure amplifying earnings swings.
Revenue remained near$3.1B from FY2023 through FY2025 while the interest burden stayed around$145M ; the earnings swing therefore reflects factors beyond top-line volume. Net margin rose to10.2% in FY2024 before falling to4.4% in FY2025, demonstrating earnings sensitivity despite stable revenue volume.
The FY2021 balance sheet paired 7.7x debt-to-equity with a 1.1x current ratio, meaning long-term obligations were large relative to equity while near-term assets only modestly exceeded near-term liabilities. That financing posture leaves net income more exposed to interest and operating variability than revenue alone suggests.
In FY2021, operating cash flow was
Financial Health Signals
Cinemark Hldgs Inc does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The metrics below are current.
Key Financial Metrics
Earnings & Revenue
Cinemark Hldgs Inc generated $3.1B in revenue in fiscal year 2025. This represents an increase of 2.1% from the prior year.
Cinemark Hldgs Inc reported $138.2M in net income in fiscal year 2025. This represents a decrease of 55.4% from the prior year.
Cinemark Hldgs Inc earned $1.04 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 49.5% from the prior year.
Not reported for fiscal year 2025.
Cash & Balance Sheet
Cinemark Hldgs Inc held $0 in cash as of fiscal year 2025; long-term debt is not reported for that period.
Cinemark Hldgs Inc paid $0.33 per share in dividends in fiscal year 2025.
Not reported for fiscal year 2025.
Margins & Returns
Cinemark Hldgs Inc's net profit margin was 4.4% in fiscal year 2025, showing the share of revenue converted to profit. This is down 5.7 percentage points from the prior year.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
Capital Allocation
None of these metrics is reported for fiscal year 2025.
CNK Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.2B | $3.1B+2.1% | $3.0B-0.6% | $3.1B+24.9% | $2.5B+62.5% | $1.5B+120.1% | $686.3M-79.1% | $3.3B+1.9% | $3.2B+7.7% | $3.0B+2.5% | $2.9B+2.3% | $2.9B+8.6% | $2.6B-2.1% | $2.7B+8.5% | $2.5B+8.5% | $2.3B |
| SG&A Expenses | N/A | N/A | N/A | N/A | N/A | $161.1M+26.2% | $127.6M-26.4% | $173.4M+5.0% | $165.2M+7.8% | $153.3M+6.9% | $143.4M-8.5% | $156.7M+3.5% | $151.4M-8.4% | $165.4M+11.3% | $148.6M+16.5% | $127.6M |
| Operating Income | N/A | N/A | N/A | N/A | N/A | -$252.5M+66.6% | -$755.0M-323.1% | $338.4M-12.9% | $388.4M-1.0% | $392.3M-7.2% | $422.9M-0.1% | $423.2M+16.5% | $363.1M-12.6% | $415.5M+8.3% | $383.7M+24.4% | $308.5M |
| Interest Expense | $138.5M | $142.3M-1.2% | $144.0M+195.7% | -$150.4M+3.2% | -$155.3M-3.7% | -$149.7M-215.2% | $129.9M+30.0% | $99.9M-9.1% | $110.0M+3.8% | $105.9M-2.2% | $108.3M-3.9% | $112.7M-0.8% | $113.7M-8.8% | $124.7M+0.8% | $123.7M+0.5% | $123.1M |
| Income Tax | N/A | $12.4M+120.6% | -$60.1M-301.0% | $29.9M+896.7% | $3.0M+117.9% | -$16.8M+94.6% | -$309.4M-487.2% | $79.9M-16.3% | $95.4M+20.3% | $79.4M-23.6% | $103.8M-19.5% | $128.9M+34.2% | $96.1M-15.2% | $113.3M-9.6% | $125.4M+71.7% | $73.0M |
| Net Income | $170.7M | $138.2M-55.4% | $309.7M+64.6% | $188.2M+169.4% | -$271.2M+35.9% | -$422.8M+31.5% | -$616.8M-422.3% | $191.4M-10.5% | $213.8M-19.1% | $264.2M+3.6% | $255.1M+17.6% | $216.9M+12.6% | $192.6M+29.7% | $148.5M-12.1% | $168.9M+29.4% | $130.6M |
| EPS (Diluted) | — | $1.04-49.5% | $2.06+53.7% | $1.34+159.3% | -$2.26+36.3% | -$3.55+32.4% | -$5.25-422.1% | $1.63-10.9% | $1.83-19.0% | $2.26+3.2% | $2.19+17.1% | $1.87+12.7% | $1.66+29.7% | $1.28-12.9% | $1.47+28.9% | $1.14 |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses.
TTM is the trailing twelve months, Q2 FY2025 through Q1 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
CNK Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | N/A | N/A | N/A | N/A | $5.2B-6.0% | $5.6B-4.5% | $5.8B+30.0% | $4.5B+0.2% | $4.5B+3.8% | $4.3B+4.4% | $4.1B+0.1% | $4.1B-0.6% | $4.1B+7.3% | $3.9B+9.7% | $3.5B |
| Current Assets | N/A | N/A | N/A | N/A | $874.4M-2.1% | $892.7M+40.6% | $635.0M+13.6% | $559.0M-15.0% | $657.6M-2.8% | $676.3M-5.4% | $715.2M-3.5% | $741.0M+1.6% | $729.6M-13.7% | $845.2M+34.8% | $627.1M |
| Cash & Equivalents | $0 | $0-100.0% | $10.8M-27.5% | $14.9M-97.9% | $707.3M+7.9% | $655.3M+34.2% | $488.3M+14.6% | $426.2M-18.4% | $522.5M-6.9% | $561.2M-4.6% | $588.5M-7.9% | $638.9M+6.5% | $599.9M-19.2% | $742.7M+42.4% | $521.4M |
| Inventory | N/A | N/A | N/A | N/A | $15.5M+23.1% | $12.6M-41.9% | $21.7M+12.3% | $19.3M+10.4% | $17.5M+3.2% | $17.0M+6.3% | $16.0M+18.9% | $13.4M-2.3% | $13.7M+9.3% | $12.6M+11.4% | $11.3M |
| Accounts Receivable | N/A | N/A | N/A | N/A | $68.8M+172.3% | $25.3M-69.8% | $83.7M-11.9% | $95.1M+6.5% | $89.3M+19.0% | $75.0M+1.0% | $74.3M+55.0% | $47.9M | N/A | N/A | N/A |
| Goodwill | $1.2B+0.5% | $1.2B-0.9% | $1.3B0.0% | $1.3B+0.2% | $1.2B-0.4% | $1.3B-2.3% | $1.3B+0.6% | $1.3B-0.6% | $1.3B+1.7% | $1.3B+1.2% | $1.2B-2.3% | $1.3B-0.8% | $1.3B+11.9% | $1.2B0.0% | $1.2B |
| Total Liabilities | N/A | N/A | N/A | N/A | $4.9B+2.8% | $4.8B+8.7% | $4.4B+42.3% | $3.1B+0.3% | $3.1B+1.1% | $3.0B+0.6% | $3.0B+0.6% | $3.0B-1.1% | $3.0B+9.4% | $2.8B+10.7% | $2.5B |
| Current Liabilities | N/A | N/A | N/A | N/A | $769.1M+26.8% | $606.4M-14.4% | $708.8M+49.3% | $474.7M+1.2% | $468.9M+5.8% | $443.2M+0.8% | $439.8M+6.1% | $414.4M+4.7% | $395.7M+17.0% | $338.2M+10.9% | $305.0M |
| Long-Term Debt | N/A | N/A | N/A | N/A | $2.5B+4.2% | $2.4B+34.2% | $1.8B-0.1% | $1.8B-0.4% | $1.8B-0.1% | $1.8B+0.5% | $1.8B-0.6% | $1.8B-2.2% | $1.8B+3.9% | $1.8B+12.5% | $1.6B |
| Total Equity | N/A | N/A | N/A | N/A | $322.9M-59.0% | $788.0M-45.1% | $1.4B+2.8% | $1.4B+0.2% | $1.4B+10.5% | $1.3B+14.7% | $1.1B-1.2% | $1.1B+0.9% | $1.1B+1.7% | $1.1B+7.0% | $1.0B |
| Retained Earnings | N/A | N/A | N/A | N/A | -$389.4M-1493.9% | $27.9M-95.9% | $687.3M+7.6% | $638.9M+9.7% | $582.2M+28.3% | $453.7M+39.8% | $324.6M+44.8% | $224.2M+51.7% | $147.8M+39.3% | $106.1M+208.3% | $34.4M |
CNK Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | N/A | N/A | N/A | N/A | N/A | $166.2M+150.4% | -$330.1M-158.7% | $562.0M+0.9% | $556.9M+5.3% | $529.0M+14.3% | $462.9M+1.5% | $455.9M+0.3% | $454.6M+46.8% | $309.7M-21.6% | $395.2M+1.0% | $391.2M |
| Capital Expenditures | N/A | N/A | N/A | N/A | $110.7M+15.9% | $95.5M+13.8% | $83.9M-72.4% | $303.6M-12.3% | $346.1M-9.1% | $380.9M+16.5% | $326.9M-1.5% | $331.7M+35.6% | $244.7M-5.8% | $259.7M+17.6% | $220.7M+19.4% | $184.8M |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | $70.7M+117.1% | -$414.0M-260.2% | $258.4M+22.5% | $210.8M+42.3% | $148.1M+8.9% | $136.0M+9.6% | $124.1M-40.9% | $209.9M+319.9% | $50.0M-71.3% | $174.5M-15.5% | $206.4M |
| Investing Cash Flow | N/A | N/A | N/A | N/A | N/A | -$89.3M-7.1% | -$83.4M+73.2% | -$310.6M+31.2% | -$451.4M-10.0% | -$410.5M-25.2% | -$327.8M | N/A | -$253.3M+30.5% | -$364.7M-55.6% | -$234.3M+5.2% | -$247.1M |
| Financing Cash Flow | N/A | N/A | N/A | N/A | N/A | -$19.9M-103.4% | $584.4M+413.3% | -$186.5M+3.2% | -$192.6M-21.9% | -$158.0M+3.5% | -$163.7M | N/A | -$146.8M-92.7% | -$76.2M-220.1% | $63.4M+180.9% | -$78.4M |
| Dividends Paid | N/A | $39.9M | N/A | N/A | N/A | $0-100.0% | $42.3M-73.4% | $159.3M+6.5% | $149.5M+10.7% | $135.1M+7.6% | $125.5M+8.3% | $115.9M+0.2% | $115.6M+9.0% | $106.0M+10.0% | $96.4M+0.6% | $95.8M |
Not reported in any period shown, so not listed: Share Buybacks.
TTM is the trailing twelve months, Q2 FY2025 through Q1 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
CNK Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | N/A | N/A | N/A | N/A | -16.7% | -110.0% | 10.3%-1.7pp | 12.0%-1.1pp | 13.1%-1.4pp | 14.5%-0.3pp | 14.8%+1.0pp | 13.8%-1.7pp | 15.5%0.0pp | 15.5%+2.0pp | 13.5% |
| Net Margin | 4.4%-5.7pp | 10.2%+4.0pp | 6.1%+17.2pp | -11.1%+16.9pp | -28.0%+61.9pp | -89.9%-95.7pp | 5.8%-0.8pp | 6.6%-2.2pp | 8.8%+0.1pp | 8.7%+1.1pp | 7.6%+0.3pp | 7.3%+1.8pp | 5.5%-1.3pp | 6.8%+1.1pp | 5.7% |
| Return on Equity | N/A | N/A | N/A | N/A | -130.9%-52.7pp | -78.3%-91.6pp | 13.3%-2.0pp | 15.3%-3.6pp | 18.9%-1.3pp | 20.2%+0.5pp | 19.7%+2.4pp | 17.3%+3.8pp | 13.5%-2.1pp | 15.6%+2.7pp | 12.9% |
| Return on Assets | N/A | N/A | N/A | N/A | -8.1%+3.0pp | -11.1%-14.4pp | 3.3%-1.5pp | 4.8%-1.1pp | 5.9%0.0pp | 5.9%+0.7pp | 5.3%+0.6pp | 4.7%+1.1pp | 3.6%-0.8pp | 4.4%+0.7pp | 3.7% |
| Current Ratio | N/A | N/A | N/A | N/A | 1.14-0.3x | 1.47+0.6x | 0.90-0.3x | 1.18-0.2x | 1.40-0.1x | 1.53-0.1x | 1.63-0.2x | 1.79-0.1x | 1.84-0.7x | 2.50+0.4x | 2.06 |
| Debt-to-Equity | N/A | N/A | N/A | N/A | 7.67+4.7x | 3.02+1.8x | 1.230.0x | 1.270.0x | 1.28-0.1x | 1.41-0.2x | 1.610.0x | 1.60-0.1x | 1.650.0x | 1.62+0.1x | 1.54 |
| FCF Margin | N/A | N/A | N/A | N/A | 4.7%+65.0pp | -60.3%-68.2pp | 7.9%+1.3pp | 6.5%+1.6pp | 5.0%+0.3pp | 4.7%+0.3pp | 4.3%-3.6pp | 8.0%+6.1pp | 1.9%-5.2pp | 7.0%-2.0pp | 9.0% |
Not reported in any period shown, so not listed: Gross Margin.
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin.
Similar Companies
Where Cinemark Hldgs Inc Ranks
Frequently Asked Questions
What is Cinemark Hldgs Inc's annual revenue?
Cinemark Hldgs Inc (CNK) reported $3.1B in total revenue for fiscal year 2025. This represents a 2.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Cinemark Hldgs Inc's revenue growing?
Cinemark Hldgs Inc (CNK) revenue grew by 2.1% year-over-year, from $3.0B to $3.1B in fiscal year 2025.
Is Cinemark Hldgs Inc profitable?
Yes, Cinemark Hldgs Inc (CNK) reported a net income of $138.2M in fiscal year 2025, with a net profit margin of 4.4%.
What is Cinemark Hldgs Inc's net profit margin?
Cinemark Hldgs Inc (CNK) had a net profit margin of 4.4% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
Does Cinemark Hldgs Inc pay dividends?
Yes, Cinemark Hldgs Inc (CNK) paid $0.33 per share in dividends during fiscal year 2025.